{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-23-080473","form_type":"8-K","ticker":"MNKD","cik":"0000899460","company_name":"MANNKIND CORP","filed_at":"2023-03-27T23:59:59+00:00","discovered_at":"2026-05-14T18:03:48.482725+00:00","generated_at":"2026-06-17T16:04:40.540871+00:00","sec_items":["5.02","7.01","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"MannKind appoints Lauren Sabella as EVP, Chief Operating Officer","bullets":["Appointment effective March 27, 2023; reports to CEO Michael Castagna.","Annual base salary $440,000; target bonus 50% of base salary.","Equity award of 210,000 RSUs vesting 25% annually over four years.","Sabella previously COO at Acorda Therapeutics; 18-year career at Boehringer Ingelheim.","Change of control agreement provides severance and accelerated vesting under certain conditions."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-23-080473","json":"https://secwatch.observer/filing/0001193125-23-080473.json","markdown":"https://secwatch.observer/filing/0001193125-23-080473.md","text":"https://secwatch.observer/filing/0001193125-23-080473.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/899460/000119312523080473/0001193125-23-080473-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/899460/000119312523080473/d490495d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-17T16:04:40.540871+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"a449205e04","claim":"Lauren M. Sabella was appointed as Executive Vice President, Chief Operating Officer at MANNKIND CORP.","evidence_excerpt":"On March 21, 2023, Lauren M. Sabella was appointed by the board of directors of MannKind Corporation (the “Company”) as Executive Vice President, Chief Operating Officer of the Company, with such appointment to be effective on March 27, 2023.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/899460/000119312523080473/0001193125-23-080473-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Executive Vice President, Chief Operating Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}